{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:15:41Z","timestamp":1789820141461,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.intimp.2022.109399","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T20:33:34Z","timestamp":1669408414000},"page":"109399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The relationships of CD8+ T cell subsets in RA patients with disease activity and clinical parameters"],"prefix":"10.1016","volume":"114","author":[{"given":"Juan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109399_b0005","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrrheum.2009.185","article-title":"Greenberg Jeffrey D, Bhardwaj Nina, Dendritic cells as targets for therapy in rheumatoid arthritis","volume":"5","author":"Shaukat","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.intimp.2022.109399_b0010","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.4049\/jimmunol.1800412","article-title":"Blocking Matrix Metalloproteinase-9 Abrogates Collagen-Induced Arthritis via Inhibiting Dendritic Cell Migration","volume":"201","author":"Juan","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2022.109399_b0015","doi-asserted-by":"crossref","unstructured":"Maldonado Anastacia, Mueller Yvonne M, Thomas Preethi, Bojczuk Paul, O'Connors Carolyn, Katsikis Peter D. Decreased effector memory CD45RA+ CD62L- CD8+ T cells and increased central memory CD45RA- CD62L+ CD8+ T cells in peripheral blood of rheumatoid arthritis patients. Arthritis Res Ther, 2003, 5: R91-6.","DOI":"10.1186\/ar619"},{"key":"10.1016\/j.intimp.2022.109399_b0020","doi-asserted-by":"crossref","unstructured":"Carvalheiro Helena, Duarte C\u00e1tia, Silva-Cardoso Sandra, da Silva Jos\u00e9 A P, Souto-Carneiro M Margarida. Carvalheiro Helena,Duarte C\u00e1tia,Silva-Cardoso Sandra et al. CD8+ T cell profiles in patients with rheumatoid arthritis and their relationship to disease activity. Arthritis Rheumatol, 2015, 67: 363-71.","DOI":"10.1002\/art.38941"},{"key":"10.1016\/j.intimp.2022.109399_b0025","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1038\/cti.2016.8","article-title":"Human lymph-node CD8(+) T cells display an altered phenotype during systemic autoimmunity","volume":"5","author":"Ramwadhdoebe Tamara","year":"2016","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.intimp.2022.109399_b0030","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/ar1017","article-title":"Leukotrienes, mast cells, and T cells","volume":"5","author":"McInnes Iain","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.intimp.2022.109399_b0035","doi-asserted-by":"crossref","unstructured":"Kang Young Mo, Zhang Xiaoyu, Wagner Ulf G, Yang Hongyu, Beckenbaugh Robert D, Kurtin Paul J, Goronzy J\u00f6rg J, Weyand Cornelia M. CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J Exp Med, 2002, 195: 1325-36.","DOI":"10.1084\/jem.20011565"},{"key":"10.1016\/j.intimp.2022.109399_b0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.autrev.2012.07.011","article-title":"da Silva Jos\u00e9 Ant\u00f3nio Pereira, Souto-Carneiro M Margarida, Potential roles for CD8(+) T cells in rheumatoid arthritis","volume":"12","author":"Helena","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.intimp.2022.109399_b0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4049\/jimmunol.179.1.36","article-title":"Yagita Hideo, Lefran\u00e7ois Leo, Cutting edge: migration to nonlymphoid tissues results in functional conversion of central to effector memory CD8 T cells","volume":"179","author":"Marzo Amanda","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2022.109399_b0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1196\/annals.1398.017","article-title":"Effector memory CD8+ T cells are resistant to apoptosis","volume":"1109","author":"Sudhir","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.intimp.2022.109399_b0055","doi-asserted-by":"crossref","unstructured":"Kverneland Anders H, Streitz Mathias, Geissler Edward, Hutchinson James, Vogt Katrin, Bo\u00ebs David, Niemann Nadja, Pedersen Anders Elm, Schlickeiser Stephan, Sawitzki Birgit. Age and gender leucocytes variances and references values generated using the standardized ONE-Study protocol. Cytometry A, 2016, 89: 543-64.","DOI":"10.1002\/cyto.a.22855"},{"key":"10.1016\/j.intimp.2022.109399_b0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrrheum.2016.74","article-title":"van Wijk Femke, CD8(+) T cells in human autoimmune arthritis: the unusual suspects","volume":"12","author":"Alessandra","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.intimp.2022.109399_b0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2567.2011.03470.x","article-title":"CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease","volume":"134","author":"Marius","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2022.109399_b0070","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.it.2009.03.013","article-title":"Akbar Arne N, Goronzy Jorg, CD28(-) T cells: their role in the age-associated decline of immune function","volume":"30","author":"Nan-Ping","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.intimp.2022.109399_b0075","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/jvi.70.3.2022-2026.1996","article-title":"Predominant involvement of CD8+CD28- lymphocytes in human immunodeficiency virus-specific cytotoxic activity","volume":"70","author":"Fiorentino","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.intimp.2022.109399_b0080","doi-asserted-by":"crossref","unstructured":"Casado Javier G, Soto Roc\u00edo, DelaRosa Olga, Peralbo Esther, del Carmen Mu\u00f1oz-Villanueva Maria, Rioja Luis, Pe\u00f1a Jos\u00e9, Solana Rafael, Tarazona Raquel. CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype. Cancer Immunol Immunother, 2005, 54: 1162-71.","DOI":"10.1007\/s00262-005-0682-5"},{"key":"10.1016\/j.intimp.2022.109399_b0085","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s10875-008-9213-4","article-title":"Association of Graves' disease and prevalence of circulating IFN-gamma-producing CD28(-) T cells","volume":"28","author":"Zhiping","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.intimp.2022.109399_b0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/ar516","article-title":"Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis","volume":"4","author":"Michael","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.intimp.2022.109399_b0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cellimm.2010.02.002","article-title":"Numerical defects in CD8+CD28- T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis","volume":"262","author":"Zuzana","year":"2010","journal-title":"Cell Immunol"},{"key":"10.1016\/j.intimp.2022.109399_b0100","doi-asserted-by":"crossref","unstructured":"Plunkett Fiona J, Franzese Ornella, Finney Helene M, Fletcher Jean M, Belaramani Lavina L, Salmon Mike, Dokal Inderjeet, Webster David, Lawson Alastair D G, Akbar Arne N. The loss of telomerase activity in highly differentiated CD8+CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation. J Immunol, 2007, 178: 7710-9.","DOI":"10.4049\/jimmunol.178.12.7710"},{"key":"10.1016\/j.intimp.2022.109399_b0105","doi-asserted-by":"crossref","unstructured":"Hollan Ivana, Ronda Nicoletta, Dessein Patrick, Agewall Stefan, Karpouzas George, Tamargo Juan, Niessner Alexander, Savarese Gianluigi, Rosano Giuseppe, Kaski Juan Carlos, Wassmann Sven, Meroni Pier Luigi. Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology. Eur Heart J Cardiovasc Pharmacother, 2020, 6: 104-114.","DOI":"10.1093\/ehjcvp\/pvz033"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922008839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922008839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:49:26Z","timestamp":1761587366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922008839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":21,"alternative-id":["S1567576922008839"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109399","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationships of CD8+ T cell subsets in RA patients with disease activity and clinical parameters","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109399"}}